Skip to content
Screener

Rapid Micro Biosystems RPID Q4 2025 Annual earnings

Reported March 12, 2026 · Before market open

Revenue$11.3MMiss by $68.0K
EPS-$0.28Miss by $0.05
Revenue estimate$11.4M
EPS estimate-$0.23

Next report

Nov 6, 2026 (in 2 months)
Revenue estimate$10.0M
EPS estimate-$0.19

Financials

Q4 2025

Income statement

See full
Revenue$11.3M+37.3%
Operating income-$12.2M-19.4%
Net income-$12.5M-29.3%
EPS (diluted)-$0.27-22.7%

Balance sheet

See full
Cash & equivalents$20.3M+17.6%
Total debt$23.9M+285%
Total equity$33.2M-55.9%
Total assets$74.9M-23.8%

Cash flow

See full
Operating cash flow-$3.2M+67.2%
CapEx$92.0K-6.1%
Free cash flow-$3.3M+66.6%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$128.54M+232%
Enterprise value$132.15M+378%
P/S3.8×+2.4×

Profitability

See full
Operating margin-141.1%-24.2pp
Net margin-140.3%-19.4pp
FCF margin-95%-27.8pp

Returns & leverage

See full
Return on equity-86.8%+326pp
Debt / equity0.7×+0.6×
Current ratio3.3×-1.3×

Segments

By product

See full
Service$2.0M-34.1%

FAQ

When did Rapid Micro Biosystems report Q4 2025 earnings?
Rapid Micro Biosystems (RPID) reported Q4 2025 earnings on March 12, 2026 before market open.
What were Rapid Micro Biosystems's Q4 2025 revenue and EPS?
Rapid Micro Biosystems reported revenue of $11.3M and eps of $-0.28 for Q4 2025.
Did Rapid Micro Biosystems beat estimates in Q4 2025?
Revenue missed the consensus estimate of $11.4M by $68.0K. EPS missed the consensus estimate of $-0.23 by $0.05.
How did Rapid Micro Biosystems's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 37.3% from $8.2M a year earlier and eps declined 27.3% from $-0.22.
Where can I find Rapid Micro Biosystems's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001380106-26-000029) and the 10-K periodic report (0001380106-26-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.